Safety and Tolerability of Quetiapine in Multiple Sclerosis
NCT02087631
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
14
Enrollment
OTHER
Sponsor class
Conditions
Multiple Sclerosis
Interventions
DRUG:
Extended-release quetiapine fumarate
Sponsor
University of Calgary
Collaborators
[object Object]